Sana Biotechnology (SANA) Current Assets (2020 - 2026)
Sana Biotechnology (SANA) posted Current Assets of $111.7 million for Q1 2026, down 24.88% sequentially from $148.7 million in Q4 2025, and down 0.92% YoY from $112.7 million in Q1 2025.
Sana Biotechnology (SANA) Current Assets (2020 - 2026) Analysis & Trends
Sana Biotechnology has reported Current Assets for 7 years, with the latest figure at $111.7 million in Q1 2026.
- Quarterly Current Assets fell 0.92% year-over-year to $111.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $111.7 million (down 0.92% YoY) and the FY2025 annual result came in at $148.7 million, down 7.54% from the prior year.
- Current Assets declined to $111.7 million in Q1 2026 per SANA's latest filing, from $148.7 million in the prior quarter.
- Over five years, Current Assets peaked at $523.2 million in Q1 2022 and troughed at $82.5 million in Q2 2025.
- A 5-year average of $278.6 million and a median of $263.5 million in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2025 and 2026: Current Assets slumped 68.68% in 2025, then declined 0.92% in 2026.
- Over 5 years, Current Assets stood at $444.4 million in 2022, then tumbled by 51.96% to $213.5 million in 2023, then slipped by 24.69% to $160.8 million in 2024, then dropped by 7.54% to $148.7 million in 2025, then declined by 24.88% to $111.7 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $111.7 million, $148.7 million, and $161.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Sana Biotechnology | 1.06 Bn | 1.06 Bn | - | 170.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 170.63 Mn |
| Mar 31, 2026 | 111.69 Mn |
| Dec 31, 2025 | 148.68 Mn |
| Sep 30, 2025 | 161.76 Mn |
| Jun 30, 2025 | 82.50 Mn |
| Mar 31, 2025 | 112.73 Mn |
| Dec 31, 2024 | 160.81 Mn |
| Sep 30, 2024 | 210.15 Mn |
| Jun 30, 2024 | 263.45 Mn |
| Mar 31, 2024 | 321.26 Mn |
| Dec 31, 2023 | 213.52 Mn |
| Sep 30, 2023 | 279.52 Mn |
| Jun 30, 2023 | 338.62 Mn |
| Mar 31, 2023 | 369.91 Mn |
| Dec 31, 2022 | 444.44 Mn |
| Sep 30, 2022 | 500.25 Mn |
| Jun 30, 2022 | 494.41 Mn |
| Mar 31, 2022 | 523.22 Mn |
| Dec 31, 2021 | 558.10 Mn |
| Sep 30, 2021 | 612.85 Mn |